Clinical trial / 2002
Shiitake mushroom mycelium extract did not lower PSA levels in prostate cancer.
Sixty-two men with histologically proven prostate cancer and elevated PSA received shiitake mushroom mycelium extract capsules three times daily for 6 months. Among 61 assessable patients, zero achieved a complete or partial PSA response, 23 developed disease progression, and 38 maintained stable PSA levels. When pre-study PSA trajectories were examined, only 4 of 61 patients (7%) demonstrated stabilized disease while taking the supplement.
- Study type
- Open-label clinical trial
- Who was studied
- 62 men with histologically proven prostate cancer (mean age 73.2 years)
- What was measured
- Prostate-specific antigen response
THE PAPER
Effects of a mushroom mycelium extract on the treatment of prostate cancer.
deVere White RW, Hackman RM, Soares SE, Beckett LA, Sun B. Urology, 2002.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.